XML 31 R6.htm IDEA: XBRL DOCUMENT v3.23.2
Consolidated Statements of Changes in Shareholders’ Equity - USD ($)
Ordinary Shares
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Total
Balance at Mar. 31, 2020 $ 30,000 $ 2,934,595 $ 3,428,173 $ 36,611 $ 6,429,379
Balance (in Shares) at Mar. 31, 2020 [1] 30,000,000        
Net income 5,044,670 5,044,670
Dividend declared (4,699,617) (4,699,617)
Foreign currency translation adjustment (20,245) (20,245)
Balance at Mar. 31, 2021 $ 30,000 2,934,595 3,773,226 16,366 6,754,187
Balance (in Shares) at Mar. 31, 2021 [1] 30,000,000        
Net income 3,491,305 3,491,305
Foreign currency translation adjustment (50,390) (50,390)
Balance at Mar. 31, 2022 $ 30,000 2,934,595 7,264,531 (34,024) 10,195,102
Balance (in Shares) at Mar. 31, 2022 [1] 30,000,000        
Net income 3,397,743 3,397,743
Foreign currency translation adjustment   115,501 115,501
Balance at Mar. 31, 2023 $ 35,005 25,172,567 10,662,274 81,477 35,951,323
Balance (in Shares) at Mar. 31, 2023 [1] 35,050,000        
Issuance of ordinary shares pursuant to initial public offering (“IPO”), net of offering cost $ 5,000 22,487,840 22,492,840
Issuance of ordinary shares pursuant to initial public offering (“IPO”), net of offering cost (in Shares) [1] 5,000,000        
Share-based compensation $ 5 50,132 50,137
Share-based compensation (in Shares) [1] 4,635        
Repurchase of warrants $ (300,000) $ (300,000)
[1] Retrospectively restated for effect of share reorganization (see Note 11).